AriaHealth.com

1-877-808-ARIA

Breast Cancer

Protocol Title Protocol Number Control Number Principal Investigator
A Clinical Trial Comparing Anastrozole with Tamoxifen in Postmenopausal Patients with Ductal Carcinoma in SITU (DCIS) Undergoing Lumpectomy with Radiation Therapy NSABP Protocol B-35 FH05-103 Dr. Allen Terzian

A Phase III Adjuvant Trial Comparing Three Chemotherapy Regimens in Women with Node-Positive Breast Cancer: Docetaxel/Doxorubicin/Cyclophosphamide (TAC) Dose-Dense (DD) Doxorubicin/Cyclophosphamide Followed by DD Paclitaxel (DD AC —> PG) NSABP Protocol B-38 STAR FH05-104 Dr. Allen Terzian

Mentor Adjunct Study for Silicone Gel Filled Mammary Prosthesis   FH05-105 Dr. George Zavitsanos

A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, II Breast Cancer RTOG #0413/NSABP B-39 FH05-106 Dr. Shari Rudoler

A Phase III Trial Evaluating the Role of Ovarian Function Suppression and the Role of Exemestane Adjuvant Therapies for Premenopausal Women with Endocrine Responsive Breast Cancer (Version 1.1 04/17/2003; Amended 10/07/2005) IBCSG 24-2 FH05-124 Dr. Allen Terzian

A Clinical Trial of Adjuvant Therapy Comparing Six Cycles of 5-Fluorouracil, Epirubicin and Cyclophosphamide (FEC) to Four Cycles of Adriamycin and Cyclophosphamide (AC) in Patients with Node-Negative Breast Cancer NSABP B-36 FH06-125 Dr. Allen Terzian